Biologics

Closeup of blue eye on black background
Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy

Just as Adverum’s cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy.
James Waldron Oct 24, 2025 9:25am
Rendered image of a respiratory syncytial virus

Sanofi drops toddler RSV vaccine after ph. 3 heads for failure

Oct 24, 2025 7:00am
Make a delay and accumulation of outstanding tasks Full stop

Regeneron does 180 on 2seventy lymphoma CAR-T

Oct 23, 2025 10:57am
gold coins and bars

Takeda strikes Innovent pact worth up to $11.4B

Oct 22, 2025 9:15am
Moderna ESMO

Moderna cancer push 'makes sense' when HHS skeptical of vaccines

Oct 22, 2025 3:00am
End of road sign on street

Galapagos to wind down cell therapy unit, threatening 365 jobs

Oct 21, 2025 9:30am